If you are wondering whether ResMed at around US$219.85 is starting to look like value or still pricing in a lot of optimism, you are in the right place. The share price has had a mixed run, with a 3.
ResMed Inc. (ASX: RMD) shares have hit a 52-week low, but the valuation, earnings growth, and sleep health opportunity look ...
California-based medical equipment manufacturer Resmed Inc. (RMD) launched a continuous and automatic positive-airway pressure (:PAP) device platform titled “AirSense 10.” The AirSense 10 series PAP ...
StockStory.org on MSN
ResMed’s (NYSE:RMD) Q1 CY2026 sales beat estimates
Medical device company ResMed (NYSE:RMD) reported in Q1 CY2026, with sales up 10.8% year on year to $1.43 billion. Its ...
RMD gears up for fiscal Q3 earnings with steady estimates, rising demand in sleep devices and AI-driven digital health tools ...
Jan 29 (Reuters) - Medical device maker ResMed (RMD.N), opens new tab on Thursday beat Wall Street estimates for second-quarter profit on the back of strong demand for its devices used to manage sleep ...
Shares of ResMed Inc. shed 8.33% to $236.18 Friday, on what proved to be an all-around dismal trading session for the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results